Measurement of blood levels of levetiracetam in patients with fits

Therapeutic drug monitoring of levetiracetam to individualize drug therapy in patients with epilepsy

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/12/010835

Enrollment

1000

Registered

2017-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Epilepsy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients on Levetiracetam for at least one year

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Seizure controlTimepoint: At one month, six months and one year when they come for blood level estimation	—

Secondary

Measure	Time frame
Proportion of patients with good seizure control, levels in patients with renal dysfunctionTimepoint: Monthly for the first six months after study initiation and six monthly subsequently	—

Countries

India

Contacts

Public ContactAishwarya Gangurde

KEM Hospital

muranjanmamta@gmail.com

Outcome results